Nisa Investment Advisors’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6K | Buy |
5,238
+181
| +4% | +$851 | ﹤0.01% | 1847 |
|
|
2025
Q1 | $18.5K | Sell |
5,057
-30
| -0.6% | -$109 | ﹤0.01% | 1914 |
|
|
2024
Q4 | $24K | Hold |
5,087
| – | – | ﹤0.01% | 1883 |
|
|
2024
Q3 | $47.4K | Buy |
5,087
+72
| +1% | +$670 | ﹤0.01% | 1657 |
|
|
2024
Q2 | $28.8K | Buy |
5,015
+11
| +0.2% | +$63 | ﹤0.01% | 1819 |
|
|
2024
Q1 | $33.6K | Buy |
5,004
+4
| +0.1% | +$27 | ﹤0.01% | 1750 |
|
|
2023
Q4 | $32.3K | Buy |
5,000
+4,437
| +788% | +$28.6K | ﹤0.01% | 1736 |
|
|
2023
Q3 | $2.82K | Buy |
563
+50
| +10% | +$250 | ﹤0.01% | 2325 |
|
|
2023
Q2 | $3.61K | Hold |
513
| – | – | ﹤0.01% | 2342 |
|
|
2023
Q1 | $3K | Sell |
513
-12
| -2% | -$70 | ﹤0.01% | 2282 |
|
|
2022
Q4 | $3K | Buy |
+525
| New | +$3K | ﹤0.01% | 2337 |
|